Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcal cysteine proteinase (SpeB) is a secreted bacterial enzyme produced by *Streptococcus pyogenes* (group A streptococcus) that plays a central role in pathogenesis by broadly degrading host and bacterial proteins[1][3][5]. SpeB is produced as a 40-kDa zymogen and activated to a 28-kDa mature protease by autocatalytic cleavage or protease assistance[1]. It exhibits proteolytic activity against plasma proteins (e.g., vitronectin, fibronectin, fibrinogen), all major human immunoglobulin isotypes (with a papain-like specificity for the IgG hinge), and proinflammatory mediators (e.g., converts pro-IL-1β to active IL-1β, releases bradykinin from H-kininogen)[1][5][7]. These activities contribute to immune evasion, tissue invasion, and the broad spectrum of disease associated with *S. pyogenes* infection. SpeB’s role extends beyond host interaction, as it can also degrade bacterial proteins and disrupt the biofilms of co-colonizing organisms such as *Staphylococcus aureus*[2]. Regulation of SpeB is complex and responsive to environmental signals, growth phase, and multiple bacterial regulators[4][8]. Due to its central role in virulence, SpeB is a potential therapeutic target, biomarker for invasive disease, and model for the study of bacterial proteases[6].
Cleavage of host and bacterial proteins, degradation of immunoglobulins (including IgG, IgA, IgM, IgD, IgE), activation of proinflammatory cytokines (e.g., IL-1β), release of kinins (e.g., bradykinin), biofilm disruption
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcal cysteine proteinase (SpeB).